Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN120732 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Spleen tyrosine Kinase (SYK) (AA 5-360) antibody
- Antibody type
- Monoclonal
- Description
- Affinity Chromatography on Protein A
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Epitope
- AA 5-360
- Isotype
- IgG
- Antibody clone number
- SYK-01
- Vial size
- 0.1 mg
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing.Shelf Life: one year from despatch.
Submitted references Topography of plasma membrane microdomains and its consequences for mast cell signaling.
A novel lipid raft-associated glycoprotein, TEC-21, activates rat basophilic leukemia cells independently of the type 1 Fc epsilon receptor.
Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation.
Vav1 regulates phospholipase cgamma activation and calcium responses in mast cells.
Structure-function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after Fcepsilon receptor I aggregation.
The Src homology 2 domain of Vav is required for its compartmentation to the plasma membrane and activation of c-Jun NH(2)-terminal kinase 1.
Requirement for a negative charge at threonine 60 of the FcRgamma for complete activation of Syk.
Direct interaction of Syk and Lyn protein tyrosine kinases in rat basophilic leukemia cells activated via type I Fc epsilon receptors.
Protein tyrosine kinase Syk is involved in Thy-1 signaling in rat basophilic leukemia cells.
Heneberg P, Lebduska P, Dráberová L, Korb J, Dráber P
European journal of immunology 2006 Oct;36(10):2795-806
European journal of immunology 2006 Oct;36(10):2795-806
A novel lipid raft-associated glycoprotein, TEC-21, activates rat basophilic leukemia cells independently of the type 1 Fc epsilon receptor.
Hálová I, Dráberová L, Dráber P
International immunology 2002 Feb;14(2):213-23
International immunology 2002 Feb;14(2):213-23
Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation.
Parravicini V, Gadina M, Kovarova M, Odom S, Gonzalez-Espinosa C, Furumoto Y, Saitoh S, Samelson LE, O'Shea JJ, Rivera J
Nature immunology 2002 Aug;3(8):741-8
Nature immunology 2002 Aug;3(8):741-8
Vav1 regulates phospholipase cgamma activation and calcium responses in mast cells.
Manetz TS, Gonzalez-Espinosa C, Arudchandran R, Xirasagar S, Tybulewicz V, Rivera J
Molecular and cellular biology 2001 Jun;21(11):3763-74
Molecular and cellular biology 2001 Jun;21(11):3763-74
Structure-function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after Fcepsilon receptor I aggregation.
Kovárová M, Tolar P, Arudchandran R, Dráberová L, Rivera J, Dráber P
Molecular and cellular biology 2001 Dec;21(24):8318-28
Molecular and cellular biology 2001 Dec;21(24):8318-28
The Src homology 2 domain of Vav is required for its compartmentation to the plasma membrane and activation of c-Jun NH(2)-terminal kinase 1.
Arudchandran R, Brown MJ, Peirce MJ, Song JS, Zhang J, Siraganian RP, Blank U, Rivera J
The Journal of experimental medicine 2000 Jan 3;191(1):47-60
The Journal of experimental medicine 2000 Jan 3;191(1):47-60
Requirement for a negative charge at threonine 60 of the FcRgamma for complete activation of Syk.
Swann PG, Odom S, Zhou YJ, Szallasi Z, Blumberg PM, Draber P, Rivera J
The Journal of biological chemistry 1999 Aug 13;274(33):23068-77
The Journal of biological chemistry 1999 Aug 13;274(33):23068-77
Direct interaction of Syk and Lyn protein tyrosine kinases in rat basophilic leukemia cells activated via type I Fc epsilon receptors.
Amoui M, Dráberová L, Tolar P, Dráber P
European journal of immunology 1997 Jan;27(1):321-8
European journal of immunology 1997 Jan;27(1):321-8
Protein tyrosine kinase Syk is involved in Thy-1 signaling in rat basophilic leukemia cells.
Tolar P, Dráberová L, Dráber P
European journal of immunology 1997 Dec;27(12):3389-97
European journal of immunology 1997 Dec;27(12):3389-97
No comments: Submit comment
No validations: Submit validation data